Fresh analysis indicates that individuals who discontinue blockbuster weight-loss injections like semaglutide or tirzepatide can put back on reduced body mass at a significantly accelerated pace than those who stop traditional diet and exercise plans.
Findings released in a prominent medical journal points out that while overweight people can lose a large proportion of their body weight while on the medication, the mass is regained at an estimated rate of nearly a kilo each month after stopping.
"Users buying such drugs should be aware of the risk of quick rebound weight gain when the treatment ends," cautioned expert Dr. Susan Jebb.
That rate of regain implies a return to pre-treatment mass within about one and a half years.
Comparing Treatments
The analysis, which looked at 37 of trials involving over 9,000 of participants, contrasted the results of GLP-1 agonists with other pills.
The team emphasize that people who lose weight through lifestyle changes alone generally see a more gradual weight regain—around 100 grams monthly—post-intervention.
Explaining the Quick Rebound
Nutrition scientists suggest the way of the jabs explains the amplified rebound.
These medications copy a natural hormone called GLP-1, which moderates appetite.
"Sustained high doses of the hormone concentrations far above than the body's typical production may cause the body to generate a reduced amount of its endogenous GLP-1, and could diminish responsiveness to its actions," explained Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this medication leads to appetite is unsuppressed, making overeating far more likely."
A Lifelong Disease?
The NHS suggest the injections for people with weight-linked medical conditions, alongside prescribed diet and exercise modifications.
A number of clinicians say that, considering the high risk of weight regain, the therapy might need to be long-term.
This perspective is echoed by pharmaceutical companies, who note that the findings "emphasize the long-term character of excess weight," comparing it to managing conditions like diabetes.
User Experiences
Individuals who have stopped the jabs describe a powerful return of cravings.
"It felt as if something flipping and I was suddenly extremely hungry," described an individual.
The struggle is exacerbated if patients have not established lasting dietary or behavioural changes during therapy.
Widespread Use
Survey data indicate that a significant number of adults in the UK have used these injections in the last 12 months, with demand remaining high.
- Adoption is higher among females than men.
- The middle-aged demographic shows the highest level of interest.
- A large proportion obtain the drugs through private healthcare rather than public health services.
Finally, experts caution that while these medications are effective agents for weight loss, they are not a standalone solution and maintained weight loss likely depends on ongoing lifestyle management.
